Correa, Simon http://orcid.org/0000-0001-9157-3987
Bonaca, Marc P.
Scirica, Benjamin M.
Murphy, Sabina A.
Goodrich, Erica L.
Morrow, David A.
O’Donoghue, Michelle L.
Article History
First Online: 3 December 2018
Compliance with ethical standards
:
: Dr. Bonaca reports grant support from Amgen, AstraZeneca, Merck, MedImmune and Pfizer; and receipt of consulting fees from Amgen, Aralez, AstraZeneca, Bayer, Janssen, Merck and Sanofi. Dr. Scirica reports research grants via Brigham and Women’s Hospital from AstraZeneca, Eisai, Novartis, and Merck; consulting fees from AstraZeneca, Biogen Idec, Boehringer Ingelheim, Covance, Dr. Reddy’s Laboratory, Eisai, Elsevier Practice Update Cardiology, GlaxoSmithKline, Lexicon, Merck, NovoNordisk, Sanofi, St. Jude’s Medical; and equity in Health [at] Scale. Dr. Morrow reports receipt of consulting fees from Abbott Laboratories, Aralez, AstraZeneca, DiaDexus, GlaxoSmithKline, Merck and Company, Peloton, Roche Diagnostics, Verseon; and research grants from Abbott, Amgen, AstraZeneca, Daichii Sankyo Ltd, GlaxoSmithKline, Merck and Company, Pfizer, Novartis Pharmaceuticals, Roche Diagnostics. Dr. O’Donoghue reports research grants from GlaxoSmithKline, Eisai, AstraZeneca, Merck, Janssen, The Medicines Company. Dr Simon Correa, Erica Goodrich and Sabina Murphy have nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: In the TRA2°P-TIMI 50 trial, informed consent was obtained from all individual participants included in the study.